SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XXII Changing the worlds Cigarette market to a safer place!!
XXII 1.530+5.5%Oct 31 9:30 AM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Julius Wong5/1/2017 10:09:19 PM
   of 56
 
22nd Century higher after FDA gives go-ahead on Brand B trial
  • Shares of 22nd Century Group (NYSEMKT: XXII) jump after the FDA grants the company authorization to conduct a clinical trial studying the company’s Brand B low tar-to-nicotine ratio cigarettes.
  • The company intends to submit a modified risk tobacco product application to the FDA.
  • Source: Press Release
  • XXII +5.71% premarket to $1.48.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News